1. Home
  2. XEL vs ONC Comparison

XEL vs ONC Comparison

Compare XEL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Energy Inc.

XEL

Xcel Energy Inc.

HOLD

Current Price

$76.51

Market Cap

47.5B

Sector

Utilities

ML Signal

HOLD

ONC

BeiGene Ltd. American Depositary Shares

HOLD

Current Price

$342.38

Market Cap

34.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XEL
ONC
Founded
1909
2010
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5B
34.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
XEL
ONC
Price
$76.51
$342.38
Analyst Decision
Buy
Strong Buy
Analyst Count
14
12
Target Price
$83.79
$369.50
AVG Volume (30 Days)
5.6M
294.7K
Earning Date
02-05-2026
02-26-2026
Dividend Yield
2.99%
N/A
EPS Growth
N/A
N/A
EPS
3.27
0.58
Revenue
$14,228,000,000.00
$4,972,687,000.00
Revenue This Year
$13.06
$895.40
Revenue Next Year
$7.62
$22.04
P/E Ratio
$23.33
$571.70
Revenue Growth
3.38
50.43
52 Week Low
$65.21
$196.45
52 Week High
$83.01
$385.22

Technical Indicators

Market Signals
Indicator
XEL
ONC
Relative Strength Index (RSI) 57.38 58.08
Support Level $74.67 $325.10
Resistance Level $76.39 $353.10
Average True Range (ATR) 1.34 10.87
MACD 0.45 2.39
Stochastic Oscillator 87.35 78.76

Price Performance

Historical Comparison
XEL
ONC

About XEL Xcel Energy Inc.

Xcel Energy manages utilities serving 3.8 million electric customers and 2.2 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan; Public Service Company of Colorado; and Southwestern Public Service Company, which serves customers in Texas and New Mexico. It is one of the largest renewable energy suppliers in the US, with more than half of its electricity sales coming from carbon-free energy.

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.

Share on Social Networks: